O’Brien, B., Penas-Prado, M., Kamiya, C., Pei Weathers, S., Yung, A., Loghin, M., . . . deGroot, J. (2019). ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. Neuro Oncol.
Chicago Style citaatO’Brien, Barbara, et al. "ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING." Neuro Oncol 2019.
MLA citatieO’Brien, Barbara, et al. "ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING." Neuro Oncol 2019.
Let op: Deze citaties zijn niet altijd 100% accuraat.